Given the uncertainty of the role that CD5L has in infection and sepsis, we established mouse models to analyze both susceptibility to disease in the absence of this circulatory factor, and also the potential benefits of administering recombinant CD5L (rCD5L) to fight the experimentally inflicted disease. This evidence concerns the gene CD5L and Sepsis.